Global and Regional Brain Monitoring
Global and Regional Brain Monitoring

Brain Monitoring Comprehensive Study by Type (Computerized Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Scanners, Positron Emission Tomography (PET) Scanners, Electroencephalograph (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)), Application (Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers, Others (Ambulances & Others)), Usability Type (Disposable, Reusable), Disease Type (Dementia, Epilepsy, Huntington's Disease, Parkinson’s Disease, Traumatic Brain Injury (TBI), Sleep Disorders, Other (Headache Disorders, Stroke and Others)), Procedure Type (Invasive Devices, Non-invasive Devices) Players and Region - Global Market Outlook to 2024

Brain Monitoring Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Nov 2019 Edition 240 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Brain Monitoring Market Scope
Brain monitoring is a procedure to monitor and diagnose abnormal activities by exploring the structure and functions of the brain. This procedure involves the use of various brain monitoring devices includes electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions and help to monitor neural and electrical activity in the brain. According to WHO, Epilepsy accounts for a significant proportion of the world’s disease burden, affecting more than 50 million people worldwide. The World Health Organization (WHO) has devised a Mental Health Action Plan 2013-2020 with certain objectives in order to provide comprehensive responsive mental health and social care services to the population. Neurological disease burden is seen higher in developing nations, which has resulted in renewed efforts by the Government and the Non-Government agencies to tackle these disease.

The market study is being classified by Type (Computerized Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Scanners, Positron Emission Tomography (PET) Scanners, Electroencephalograph (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices and Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)), by Application (Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers and Others (Ambulances & Others)) and major geographies with country level break-up.

Advanced Brain Monitoring (United States), Nihon Kohden Corporation (Japan), Natus Medical, Inc. (United States), Philips Healthcare (Netherlands), GE Healthcare (United States), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (United States), Drägerwerk AG & Co. KGaA (Germany), Masimo Corporation (United States), Spiegelberg GmbH & Co. KG (Germany) and Cadwell Industries (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are NeuroWave Systems, Inc. (United States), Nonin Medical, Inc. (United States), Integra LifeSciences Corporation (United States), Neurosoft (Russia) and Rimed (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Brain Monitoring market by Type, Application and Region.

On the basis of geography, the market of Brain Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Technological Advancements and Innovations in Products

Market Drivers
  • Rising Incidence and Prevalence of Neurological Disorders Globally
  • Increasing Awareness About Neurodegenerative Disorders Diseases,
  • The Growth in the Number of Traumatic Brain Injuries

Opportunities
  • Increasing Applications of Brain Monitoring In Clinical Trials
  • Growing Demand for Invasive devices and Increasing Application in Clinical Trials
  • Expansion of Therapeutic Applications of Brain Monitoring Devices is Providing an Opportunity to the Market Players

Restraints
  • The Dearth of Skilled Professionals to Effectively Operate Brain Monitoring Devices in Developing Nations
  • Unfavourable Reimbursement Policies

Challenges
  • The Cost Factor Associated with these Types of Equipment Used to Monitor Brain Activity


Key Target Audience
Brain Monitoring Device and Equipment Manufacturers, Distributors/Traders/Wholesalers, Brain Monitoring Device Subcomponent Manufacturers, Industry Association, Diagnostic Centers, Neurological Centers, Health Centers/Clinics, End Users and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Computerized Tomography (CT) Scanners
  • Magnetic Resonance Imaging (MRI) Scanners
  • Positron Emission Tomography (PET) Scanners
  • Electroencephalograph (EEG) Devices
  • Magnetoencephalography (MEG) Devices
  • Transcranial Doppler (TCD) Devices
  • Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
By Application
  • Hospitals
  • Neurology Centers
  • Clinics & Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others (Ambulances & Others)
By Usability Type
  • Disposable
  • Reusable

By Disease Type
  • Dementia
  • Epilepsy
  • Huntington's Disease
  • Parkinson’s Disease
  • Traumatic Brain Injury (TBI)
  • Sleep Disorders
  • Other (Headache Disorders, Stroke and Others)

By Procedure Type
  • Invasive Devices
  • Non-invasive Devices

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence and Prevalence of Neurological Disorders Globally
      • 3.2.2. Increasing Awareness About Neurodegenerative Disorders Diseases,
      • 3.2.3. The Growth in the Number of Traumatic Brain Injuries
    • 3.3. Market Challenges
      • 3.3.1. The Cost Factor Associated with these Types of Equipment Used to Monitor Brain Activity
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements and Innovations in Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Brain Monitoring, by Type, Application, Usability Type, Disease Type, Procedure Type and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Brain Monitoring (Value)
      • 5.2.1. Global Brain Monitoring by: Type (Value)
        • 5.2.1.1. Computerized Tomography (CT) Scanners
        • 5.2.1.2. Magnetic Resonance Imaging (MRI) Scanners
        • 5.2.1.3. Positron Emission Tomography (PET) Scanners
        • 5.2.1.4. Electroencephalograph (EEG) Devices
        • 5.2.1.5. Magnetoencephalography (MEG) Devices
        • 5.2.1.6. Transcranial Doppler (TCD) Devices
        • 5.2.1.7. Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
      • 5.2.2. Global Brain Monitoring by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Neurology Centers
        • 5.2.2.3. Clinics & Ambulatory Surgical Centers
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Others (Ambulances & Others)
      • 5.2.3. Global Brain Monitoring by: Usability Type (Value)
        • 5.2.3.1. Disposable
        • 5.2.3.2. Reusable
      • 5.2.4. Global Brain Monitoring by: Disease Type (Value)
        • 5.2.4.1. Dementia
        • 5.2.4.2. Epilepsy
        • 5.2.4.3. Huntington's Disease
        • 5.2.4.4. Parkinson’s Disease
        • 5.2.4.5. Traumatic Brain Injury (TBI)
        • 5.2.4.6. Sleep Disorders
        • 5.2.4.7. Other (Headache Disorders, Stroke and Others)
      • 5.2.5. Global Brain Monitoring by: Procedure Type (Value)
        • 5.2.5.1. Invasive Devices
        • 5.2.5.2. Non-invasive Devices
      • 5.2.6. Global Brain Monitoring Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Brain Monitoring (Volume)
      • 5.3.1. Global Brain Monitoring by: Type (Volume)
        • 5.3.1.1. Computerized Tomography (CT) Scanners
        • 5.3.1.2. Magnetic Resonance Imaging (MRI) Scanners
        • 5.3.1.3. Positron Emission Tomography (PET) Scanners
        • 5.3.1.4. Electroencephalograph (EEG) Devices
        • 5.3.1.5. Magnetoencephalography (MEG) Devices
        • 5.3.1.6. Transcranial Doppler (TCD) Devices
        • 5.3.1.7. Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
      • 5.3.2. Global Brain Monitoring by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Neurology Centers
        • 5.3.2.3. Clinics & Ambulatory Surgical Centers
        • 5.3.2.4. Diagnostic Centers
        • 5.3.2.5. Others (Ambulances & Others)
      • 5.3.3. Global Brain Monitoring by: Usability Type (Volume)
        • 5.3.3.1. Disposable
        • 5.3.3.2. Reusable
      • 5.3.4. Global Brain Monitoring by: Disease Type (Volume)
        • 5.3.4.1. Dementia
        • 5.3.4.2. Epilepsy
        • 5.3.4.3. Huntington's Disease
        • 5.3.4.4. Parkinson’s Disease
        • 5.3.4.5. Traumatic Brain Injury (TBI)
        • 5.3.4.6. Sleep Disorders
        • 5.3.4.7. Other (Headache Disorders, Stroke and Others)
      • 5.3.5. Global Brain Monitoring by: Procedure Type (Volume)
        • 5.3.5.1. Invasive Devices
        • 5.3.5.2. Non-invasive Devices
      • 5.3.6. Global Brain Monitoring Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Brain Monitoring (Price)
      • 5.4.1. Global Brain Monitoring by: Type (Price)
  • 6. Brain Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced Brain Monitoring (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nihon Kohden Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Natus Medical, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Philips Healthcare (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GE Healthcare (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Siemens Healthineers (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Compumedics, Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CAS Medical Systems, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Drägerwerk AG & Co. KGaA (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Masimo Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Spiegelberg GmbH & Co. KG (Germany)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Cadwell Industries (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Brain Monitoring Sale, by Type, Application, Usability Type, Disease Type, Procedure Type and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Brain Monitoring (Value)
      • 7.2.1. Global Brain Monitoring by: Type (Value)
        • 7.2.1.1. Computerized Tomography (CT) Scanners
        • 7.2.1.2. Magnetic Resonance Imaging (MRI) Scanners
        • 7.2.1.3. Positron Emission Tomography (PET) Scanners
        • 7.2.1.4. Electroencephalograph (EEG) Devices
        • 7.2.1.5. Magnetoencephalography (MEG) Devices
        • 7.2.1.6. Transcranial Doppler (TCD) Devices
        • 7.2.1.7. Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
      • 7.2.2. Global Brain Monitoring by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Neurology Centers
        • 7.2.2.3. Clinics & Ambulatory Surgical Centers
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Others (Ambulances & Others)
      • 7.2.3. Global Brain Monitoring by: Usability Type (Value)
        • 7.2.3.1. Disposable
        • 7.2.3.2. Reusable
      • 7.2.4. Global Brain Monitoring by: Disease Type (Value)
        • 7.2.4.1. Dementia
        • 7.2.4.2. Epilepsy
        • 7.2.4.3. Huntington's Disease
        • 7.2.4.4. Parkinson’s Disease
        • 7.2.4.5. Traumatic Brain Injury (TBI)
        • 7.2.4.6. Sleep Disorders
        • 7.2.4.7. Other (Headache Disorders, Stroke and Others)
      • 7.2.5. Global Brain Monitoring by: Procedure Type (Value)
        • 7.2.5.1. Invasive Devices
        • 7.2.5.2. Non-invasive Devices
      • 7.2.6. Global Brain Monitoring Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Brain Monitoring (Volume)
      • 7.3.1. Global Brain Monitoring by: Type (Volume)
        • 7.3.1.1. Computerized Tomography (CT) Scanners
        • 7.3.1.2. Magnetic Resonance Imaging (MRI) Scanners
        • 7.3.1.3. Positron Emission Tomography (PET) Scanners
        • 7.3.1.4. Electroencephalograph (EEG) Devices
        • 7.3.1.5. Magnetoencephalography (MEG) Devices
        • 7.3.1.6. Transcranial Doppler (TCD) Devices
        • 7.3.1.7. Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
      • 7.3.2. Global Brain Monitoring by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Neurology Centers
        • 7.3.2.3. Clinics & Ambulatory Surgical Centers
        • 7.3.2.4. Diagnostic Centers
        • 7.3.2.5. Others (Ambulances & Others)
      • 7.3.3. Global Brain Monitoring by: Usability Type (Volume)
        • 7.3.3.1. Disposable
        • 7.3.3.2. Reusable
      • 7.3.4. Global Brain Monitoring by: Disease Type (Volume)
        • 7.3.4.1. Dementia
        • 7.3.4.2. Epilepsy
        • 7.3.4.3. Huntington's Disease
        • 7.3.4.4. Parkinson’s Disease
        • 7.3.4.5. Traumatic Brain Injury (TBI)
        • 7.3.4.6. Sleep Disorders
        • 7.3.4.7. Other (Headache Disorders, Stroke and Others)
      • 7.3.5. Global Brain Monitoring by: Procedure Type (Volume)
        • 7.3.5.1. Invasive Devices
        • 7.3.5.2. Non-invasive Devices
      • 7.3.6. Global Brain Monitoring Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Brain Monitoring (Price)
      • 7.4.1. Global Brain Monitoring by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Brain Monitoring: by Type(USD Million)
  • Table 2. Brain Monitoring Computerized Tomography (CT) Scanners , by Region USD Million (2013-2018)
  • Table 3. Brain Monitoring Magnetic Resonance Imaging (MRI) Scanners , by Region USD Million (2013-2018)
  • Table 4. Brain Monitoring Positron Emission Tomography (PET) Scanners , by Region USD Million (2013-2018)
  • Table 5. Brain Monitoring Electroencephalograph (EEG) Devices , by Region USD Million (2013-2018)
  • Table 6. Brain Monitoring Magnetoencephalography (MEG) Devices , by Region USD Million (2013-2018)
  • Table 7. Brain Monitoring Transcranial Doppler (TCD) Devices , by Region USD Million (2013-2018)
  • Table 8. Brain Monitoring Others (Sleep Monitoring Devices, Cerebral Oximeters and Others) , by Region USD Million (2013-2018)
  • Table 9. Brain Monitoring: by Application(USD Million)
  • Table 10. Brain Monitoring Hospitals , by Region USD Million (2013-2018)
  • Table 11. Brain Monitoring Neurology Centers , by Region USD Million (2013-2018)
  • Table 12. Brain Monitoring Clinics & Ambulatory Surgical Centers , by Region USD Million (2013-2018)
  • Table 13. Brain Monitoring Diagnostic Centers , by Region USD Million (2013-2018)
  • Table 14. Brain Monitoring Others (Ambulances & Others) , by Region USD Million (2013-2018)
  • Table 15. Brain Monitoring: by Usability Type(USD Million)
  • Table 16. Brain Monitoring Disposable , by Region USD Million (2013-2018)
  • Table 17. Brain Monitoring Reusable , by Region USD Million (2013-2018)
  • Table 18. Brain Monitoring: by Disease Type(USD Million)
  • Table 19. Brain Monitoring Dementia , by Region USD Million (2013-2018)
  • Table 20. Brain Monitoring Epilepsy , by Region USD Million (2013-2018)
  • Table 21. Brain Monitoring Huntington's Disease , by Region USD Million (2013-2018)
  • Table 22. Brain Monitoring Parkinson’s Disease , by Region USD Million (2013-2018)
  • Table 23. Brain Monitoring Traumatic Brain Injury (TBI) , by Region USD Million (2013-2018)
  • Table 24. Brain Monitoring Sleep Disorders , by Region USD Million (2013-2018)
  • Table 25. Brain Monitoring Other (Headache Disorders, Stroke and Others) , by Region USD Million (2013-2018)
  • Table 26. Brain Monitoring: by Procedure Type(USD Million)
  • Table 27. Brain Monitoring Invasive Devices , by Region USD Million (2013-2018)
  • Table 28. Brain Monitoring Non-invasive Devices , by Region USD Million (2013-2018)
  • Table 29. South America Brain Monitoring, by Country USD Million (2013-2018)
  • Table 30. South America Brain Monitoring, by Type USD Million (2013-2018)
  • Table 31. South America Brain Monitoring, by Application USD Million (2013-2018)
  • Table 32. South America Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 33. South America Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 34. South America Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 35. Brazil Brain Monitoring, by Type USD Million (2013-2018)
  • Table 36. Brazil Brain Monitoring, by Application USD Million (2013-2018)
  • Table 37. Brazil Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 38. Brazil Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 39. Brazil Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 40. Argentina Brain Monitoring, by Type USD Million (2013-2018)
  • Table 41. Argentina Brain Monitoring, by Application USD Million (2013-2018)
  • Table 42. Argentina Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 43. Argentina Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 44. Argentina Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 45. Rest of South America Brain Monitoring, by Type USD Million (2013-2018)
  • Table 46. Rest of South America Brain Monitoring, by Application USD Million (2013-2018)
  • Table 47. Rest of South America Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 48. Rest of South America Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 49. Rest of South America Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 50. Asia Pacific Brain Monitoring, by Country USD Million (2013-2018)
  • Table 51. Asia Pacific Brain Monitoring, by Type USD Million (2013-2018)
  • Table 52. Asia Pacific Brain Monitoring, by Application USD Million (2013-2018)
  • Table 53. Asia Pacific Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 54. Asia Pacific Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 55. Asia Pacific Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 56. China Brain Monitoring, by Type USD Million (2013-2018)
  • Table 57. China Brain Monitoring, by Application USD Million (2013-2018)
  • Table 58. China Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 59. China Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 60. China Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 61. Japan Brain Monitoring, by Type USD Million (2013-2018)
  • Table 62. Japan Brain Monitoring, by Application USD Million (2013-2018)
  • Table 63. Japan Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 64. Japan Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 65. Japan Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 66. India Brain Monitoring, by Type USD Million (2013-2018)
  • Table 67. India Brain Monitoring, by Application USD Million (2013-2018)
  • Table 68. India Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 69. India Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 70. India Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 71. South Korea Brain Monitoring, by Type USD Million (2013-2018)
  • Table 72. South Korea Brain Monitoring, by Application USD Million (2013-2018)
  • Table 73. South Korea Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 74. South Korea Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 75. South Korea Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 76. Taiwan Brain Monitoring, by Type USD Million (2013-2018)
  • Table 77. Taiwan Brain Monitoring, by Application USD Million (2013-2018)
  • Table 78. Taiwan Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 79. Taiwan Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 80. Taiwan Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 81. Australia Brain Monitoring, by Type USD Million (2013-2018)
  • Table 82. Australia Brain Monitoring, by Application USD Million (2013-2018)
  • Table 83. Australia Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 84. Australia Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 85. Australia Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 86. Rest of Asia-Pacific Brain Monitoring, by Type USD Million (2013-2018)
  • Table 87. Rest of Asia-Pacific Brain Monitoring, by Application USD Million (2013-2018)
  • Table 88. Rest of Asia-Pacific Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 89. Rest of Asia-Pacific Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 90. Rest of Asia-Pacific Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 91. Europe Brain Monitoring, by Country USD Million (2013-2018)
  • Table 92. Europe Brain Monitoring, by Type USD Million (2013-2018)
  • Table 93. Europe Brain Monitoring, by Application USD Million (2013-2018)
  • Table 94. Europe Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 95. Europe Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 96. Europe Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 97. Germany Brain Monitoring, by Type USD Million (2013-2018)
  • Table 98. Germany Brain Monitoring, by Application USD Million (2013-2018)
  • Table 99. Germany Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 100. Germany Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 101. Germany Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 102. France Brain Monitoring, by Type USD Million (2013-2018)
  • Table 103. France Brain Monitoring, by Application USD Million (2013-2018)
  • Table 104. France Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 105. France Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 106. France Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 107. Italy Brain Monitoring, by Type USD Million (2013-2018)
  • Table 108. Italy Brain Monitoring, by Application USD Million (2013-2018)
  • Table 109. Italy Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 110. Italy Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 111. Italy Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 112. United Kingdom Brain Monitoring, by Type USD Million (2013-2018)
  • Table 113. United Kingdom Brain Monitoring, by Application USD Million (2013-2018)
  • Table 114. United Kingdom Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 115. United Kingdom Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 116. United Kingdom Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 117. Netherlands Brain Monitoring, by Type USD Million (2013-2018)
  • Table 118. Netherlands Brain Monitoring, by Application USD Million (2013-2018)
  • Table 119. Netherlands Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 120. Netherlands Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 121. Netherlands Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 122. Rest of Europe Brain Monitoring, by Type USD Million (2013-2018)
  • Table 123. Rest of Europe Brain Monitoring, by Application USD Million (2013-2018)
  • Table 124. Rest of Europe Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 125. Rest of Europe Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 126. Rest of Europe Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 127. MEA Brain Monitoring, by Country USD Million (2013-2018)
  • Table 128. MEA Brain Monitoring, by Type USD Million (2013-2018)
  • Table 129. MEA Brain Monitoring, by Application USD Million (2013-2018)
  • Table 130. MEA Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 131. MEA Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 132. MEA Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 133. Middle East Brain Monitoring, by Type USD Million (2013-2018)
  • Table 134. Middle East Brain Monitoring, by Application USD Million (2013-2018)
  • Table 135. Middle East Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 136. Middle East Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 137. Middle East Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 138. Africa Brain Monitoring, by Type USD Million (2013-2018)
  • Table 139. Africa Brain Monitoring, by Application USD Million (2013-2018)
  • Table 140. Africa Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 141. Africa Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 142. Africa Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 143. North America Brain Monitoring, by Country USD Million (2013-2018)
  • Table 144. North America Brain Monitoring, by Type USD Million (2013-2018)
  • Table 145. North America Brain Monitoring, by Application USD Million (2013-2018)
  • Table 146. North America Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 147. North America Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 148. North America Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 149. United States Brain Monitoring, by Type USD Million (2013-2018)
  • Table 150. United States Brain Monitoring, by Application USD Million (2013-2018)
  • Table 151. United States Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 152. United States Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 153. United States Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 154. Canada Brain Monitoring, by Type USD Million (2013-2018)
  • Table 155. Canada Brain Monitoring, by Application USD Million (2013-2018)
  • Table 156. Canada Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 157. Canada Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 158. Canada Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 159. Mexico Brain Monitoring, by Type USD Million (2013-2018)
  • Table 160. Mexico Brain Monitoring, by Application USD Million (2013-2018)
  • Table 161. Mexico Brain Monitoring, by Usability Type USD Million (2013-2018)
  • Table 162. Mexico Brain Monitoring, by Disease Type USD Million (2013-2018)
  • Table 163. Mexico Brain Monitoring, by Procedure Type USD Million (2013-2018)
  • Table 164. Brain Monitoring Sales: by Type(K Units)
  • Table 165. Brain Monitoring Sales Computerized Tomography (CT) Scanners , by Region K Units (2013-2018)
  • Table 166. Brain Monitoring Sales Magnetic Resonance Imaging (MRI) Scanners , by Region K Units (2013-2018)
  • Table 167. Brain Monitoring Sales Positron Emission Tomography (PET) Scanners , by Region K Units (2013-2018)
  • Table 168. Brain Monitoring Sales Electroencephalograph (EEG) Devices , by Region K Units (2013-2018)
  • Table 169. Brain Monitoring Sales Magnetoencephalography (MEG) Devices , by Region K Units (2013-2018)
  • Table 170. Brain Monitoring Sales Transcranial Doppler (TCD) Devices , by Region K Units (2013-2018)
  • Table 171. Brain Monitoring Sales Others (Sleep Monitoring Devices, Cerebral Oximeters and Others) , by Region K Units (2013-2018)
  • Table 172. Brain Monitoring Sales: by Application(K Units)
  • Table 173. Brain Monitoring Sales Hospitals , by Region K Units (2013-2018)
  • Table 174. Brain Monitoring Sales Neurology Centers , by Region K Units (2013-2018)
  • Table 175. Brain Monitoring Sales Clinics & Ambulatory Surgical Centers , by Region K Units (2013-2018)
  • Table 176. Brain Monitoring Sales Diagnostic Centers , by Region K Units (2013-2018)
  • Table 177. Brain Monitoring Sales Others (Ambulances & Others) , by Region K Units (2013-2018)
  • Table 178. Brain Monitoring Sales: by Usability Type(K Units)
  • Table 179. Brain Monitoring Sales Disposable , by Region K Units (2013-2018)
  • Table 180. Brain Monitoring Sales Reusable , by Region K Units (2013-2018)
  • Table 181. Brain Monitoring Sales: by Disease Type(K Units)
  • Table 182. Brain Monitoring Sales Dementia , by Region K Units (2013-2018)
  • Table 183. Brain Monitoring Sales Epilepsy , by Region K Units (2013-2018)
  • Table 184. Brain Monitoring Sales Huntington's Disease , by Region K Units (2013-2018)
  • Table 185. Brain Monitoring Sales Parkinson’s Disease , by Region K Units (2013-2018)
  • Table 186. Brain Monitoring Sales Traumatic Brain Injury (TBI) , by Region K Units (2013-2018)
  • Table 187. Brain Monitoring Sales Sleep Disorders , by Region K Units (2013-2018)
  • Table 188. Brain Monitoring Sales Other (Headache Disorders, Stroke and Others) , by Region K Units (2013-2018)
  • Table 189. Brain Monitoring Sales: by Procedure Type(K Units)
  • Table 190. Brain Monitoring Sales Invasive Devices , by Region K Units (2013-2018)
  • Table 191. Brain Monitoring Sales Non-invasive Devices , by Region K Units (2013-2018)
  • Table 192. South America Brain Monitoring Sales, by Country K Units (2013-2018)
  • Table 193. South America Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 194. South America Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 195. South America Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 196. South America Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 197. South America Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 198. Brazil Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 199. Brazil Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 200. Brazil Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 201. Brazil Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 202. Brazil Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 203. Argentina Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 204. Argentina Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 205. Argentina Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 206. Argentina Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 207. Argentina Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 208. Rest of South America Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 209. Rest of South America Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 210. Rest of South America Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 211. Rest of South America Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 212. Rest of South America Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 213. Asia Pacific Brain Monitoring Sales, by Country K Units (2013-2018)
  • Table 214. Asia Pacific Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 215. Asia Pacific Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 216. Asia Pacific Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 217. Asia Pacific Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 218. Asia Pacific Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 219. China Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 220. China Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 221. China Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 222. China Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 223. China Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 224. Japan Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 225. Japan Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 226. Japan Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 227. Japan Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 228. Japan Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 229. India Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 230. India Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 231. India Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 232. India Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 233. India Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 234. South Korea Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 235. South Korea Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 236. South Korea Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 237. South Korea Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 238. South Korea Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 239. Taiwan Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 240. Taiwan Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 241. Taiwan Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 242. Taiwan Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 243. Taiwan Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 244. Australia Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 245. Australia Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 246. Australia Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 247. Australia Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 248. Australia Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 249. Rest of Asia-Pacific Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 250. Rest of Asia-Pacific Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 251. Rest of Asia-Pacific Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 252. Rest of Asia-Pacific Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 253. Rest of Asia-Pacific Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 254. Europe Brain Monitoring Sales, by Country K Units (2013-2018)
  • Table 255. Europe Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 256. Europe Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 257. Europe Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 258. Europe Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 259. Europe Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 260. Germany Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 261. Germany Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 262. Germany Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 263. Germany Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 264. Germany Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 265. France Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 266. France Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 267. France Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 268. France Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 269. France Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 270. Italy Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 271. Italy Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 272. Italy Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 273. Italy Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 274. Italy Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 275. United Kingdom Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 276. United Kingdom Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 277. United Kingdom Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 278. United Kingdom Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 279. United Kingdom Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 280. Netherlands Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 281. Netherlands Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 282. Netherlands Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 283. Netherlands Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 284. Netherlands Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 285. Rest of Europe Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 286. Rest of Europe Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 287. Rest of Europe Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 288. Rest of Europe Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 289. Rest of Europe Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 290. MEA Brain Monitoring Sales, by Country K Units (2013-2018)
  • Table 291. MEA Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 292. MEA Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 293. MEA Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 294. MEA Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 295. MEA Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 296. Middle East Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 297. Middle East Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 298. Middle East Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 299. Middle East Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 300. Middle East Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 301. Africa Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 302. Africa Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 303. Africa Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 304. Africa Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 305. Africa Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 306. North America Brain Monitoring Sales, by Country K Units (2013-2018)
  • Table 307. North America Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 308. North America Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 309. North America Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 310. North America Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 311. North America Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 312. United States Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 313. United States Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 314. United States Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 315. United States Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 316. United States Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 317. Canada Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 318. Canada Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 319. Canada Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 320. Canada Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 321. Canada Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 322. Mexico Brain Monitoring Sales, by Type K Units (2013-2018)
  • Table 323. Mexico Brain Monitoring Sales, by Application K Units (2013-2018)
  • Table 324. Mexico Brain Monitoring Sales, by Usability Type K Units (2013-2018)
  • Table 325. Mexico Brain Monitoring Sales, by Disease Type K Units (2013-2018)
  • Table 326. Mexico Brain Monitoring Sales, by Procedure Type K Units (2013-2018)
  • Table 327. Brain Monitoring: by Type(USD/Units)
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Company Basic Information, Sales Area and Its Competitors
  • Table 332. Company Basic Information, Sales Area and Its Competitors
  • Table 333. Company Basic Information, Sales Area and Its Competitors
  • Table 334. Company Basic Information, Sales Area and Its Competitors
  • Table 335. Company Basic Information, Sales Area and Its Competitors
  • Table 336. Company Basic Information, Sales Area and Its Competitors
  • Table 337. Company Basic Information, Sales Area and Its Competitors
  • Table 338. Company Basic Information, Sales Area and Its Competitors
  • Table 339. Company Basic Information, Sales Area and Its Competitors
  • Table 340. Company Basic Information, Sales Area and Its Competitors
  • Table 341. Brain Monitoring: by Type(USD Million)
  • Table 342. Brain Monitoring Computerized Tomography (CT) Scanners , by Region USD Million (2019-2024)
  • Table 343. Brain Monitoring Magnetic Resonance Imaging (MRI) Scanners , by Region USD Million (2019-2024)
  • Table 344. Brain Monitoring Positron Emission Tomography (PET) Scanners , by Region USD Million (2019-2024)
  • Table 345. Brain Monitoring Electroencephalograph (EEG) Devices , by Region USD Million (2019-2024)
  • Table 346. Brain Monitoring Magnetoencephalography (MEG) Devices , by Region USD Million (2019-2024)
  • Table 347. Brain Monitoring Transcranial Doppler (TCD) Devices , by Region USD Million (2019-2024)
  • Table 348. Brain Monitoring Others (Sleep Monitoring Devices, Cerebral Oximeters and Others) , by Region USD Million (2019-2024)
  • Table 349. Brain Monitoring: by Application(USD Million)
  • Table 350. Brain Monitoring Hospitals , by Region USD Million (2019-2024)
  • Table 351. Brain Monitoring Neurology Centers , by Region USD Million (2019-2024)
  • Table 352. Brain Monitoring Clinics & Ambulatory Surgical Centers , by Region USD Million (2019-2024)
  • Table 353. Brain Monitoring Diagnostic Centers , by Region USD Million (2019-2024)
  • Table 354. Brain Monitoring Others (Ambulances & Others) , by Region USD Million (2019-2024)
  • Table 355. Brain Monitoring: by Usability Type(USD Million)
  • Table 356. Brain Monitoring Disposable , by Region USD Million (2019-2024)
  • Table 357. Brain Monitoring Reusable , by Region USD Million (2019-2024)
  • Table 358. Brain Monitoring: by Disease Type(USD Million)
  • Table 359. Brain Monitoring Dementia , by Region USD Million (2019-2024)
  • Table 360. Brain Monitoring Epilepsy , by Region USD Million (2019-2024)
  • Table 361. Brain Monitoring Huntington's Disease , by Region USD Million (2019-2024)
  • Table 362. Brain Monitoring Parkinson’s Disease , by Region USD Million (2019-2024)
  • Table 363. Brain Monitoring Traumatic Brain Injury (TBI) , by Region USD Million (2019-2024)
  • Table 364. Brain Monitoring Sleep Disorders , by Region USD Million (2019-2024)
  • Table 365. Brain Monitoring Other (Headache Disorders, Stroke and Others) , by Region USD Million (2019-2024)
  • Table 366. Brain Monitoring: by Procedure Type(USD Million)
  • Table 367. Brain Monitoring Invasive Devices , by Region USD Million (2019-2024)
  • Table 368. Brain Monitoring Non-invasive Devices , by Region USD Million (2019-2024)
  • Table 369. South America Brain Monitoring, by Country USD Million (2019-2024)
  • Table 370. South America Brain Monitoring, by Type USD Million (2019-2024)
  • Table 371. South America Brain Monitoring, by Application USD Million (2019-2024)
  • Table 372. South America Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 373. South America Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 374. South America Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 375. Brazil Brain Monitoring, by Type USD Million (2019-2024)
  • Table 376. Brazil Brain Monitoring, by Application USD Million (2019-2024)
  • Table 377. Brazil Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 378. Brazil Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 379. Brazil Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 380. Argentina Brain Monitoring, by Type USD Million (2019-2024)
  • Table 381. Argentina Brain Monitoring, by Application USD Million (2019-2024)
  • Table 382. Argentina Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 383. Argentina Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 384. Argentina Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 385. Rest of South America Brain Monitoring, by Type USD Million (2019-2024)
  • Table 386. Rest of South America Brain Monitoring, by Application USD Million (2019-2024)
  • Table 387. Rest of South America Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 388. Rest of South America Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 389. Rest of South America Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 390. Asia Pacific Brain Monitoring, by Country USD Million (2019-2024)
  • Table 391. Asia Pacific Brain Monitoring, by Type USD Million (2019-2024)
  • Table 392. Asia Pacific Brain Monitoring, by Application USD Million (2019-2024)
  • Table 393. Asia Pacific Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 394. Asia Pacific Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 395. Asia Pacific Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 396. China Brain Monitoring, by Type USD Million (2019-2024)
  • Table 397. China Brain Monitoring, by Application USD Million (2019-2024)
  • Table 398. China Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 399. China Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 400. China Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 401. Japan Brain Monitoring, by Type USD Million (2019-2024)
  • Table 402. Japan Brain Monitoring, by Application USD Million (2019-2024)
  • Table 403. Japan Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 404. Japan Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 405. Japan Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 406. India Brain Monitoring, by Type USD Million (2019-2024)
  • Table 407. India Brain Monitoring, by Application USD Million (2019-2024)
  • Table 408. India Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 409. India Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 410. India Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 411. South Korea Brain Monitoring, by Type USD Million (2019-2024)
  • Table 412. South Korea Brain Monitoring, by Application USD Million (2019-2024)
  • Table 413. South Korea Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 414. South Korea Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 415. South Korea Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 416. Taiwan Brain Monitoring, by Type USD Million (2019-2024)
  • Table 417. Taiwan Brain Monitoring, by Application USD Million (2019-2024)
  • Table 418. Taiwan Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 419. Taiwan Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 420. Taiwan Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 421. Australia Brain Monitoring, by Type USD Million (2019-2024)
  • Table 422. Australia Brain Monitoring, by Application USD Million (2019-2024)
  • Table 423. Australia Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 424. Australia Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 425. Australia Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 426. Rest of Asia-Pacific Brain Monitoring, by Type USD Million (2019-2024)
  • Table 427. Rest of Asia-Pacific Brain Monitoring, by Application USD Million (2019-2024)
  • Table 428. Rest of Asia-Pacific Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 429. Rest of Asia-Pacific Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 430. Rest of Asia-Pacific Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 431. Europe Brain Monitoring, by Country USD Million (2019-2024)
  • Table 432. Europe Brain Monitoring, by Type USD Million (2019-2024)
  • Table 433. Europe Brain Monitoring, by Application USD Million (2019-2024)
  • Table 434. Europe Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 435. Europe Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 436. Europe Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 437. Germany Brain Monitoring, by Type USD Million (2019-2024)
  • Table 438. Germany Brain Monitoring, by Application USD Million (2019-2024)
  • Table 439. Germany Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 440. Germany Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 441. Germany Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 442. France Brain Monitoring, by Type USD Million (2019-2024)
  • Table 443. France Brain Monitoring, by Application USD Million (2019-2024)
  • Table 444. France Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 445. France Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 446. France Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 447. Italy Brain Monitoring, by Type USD Million (2019-2024)
  • Table 448. Italy Brain Monitoring, by Application USD Million (2019-2024)
  • Table 449. Italy Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 450. Italy Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 451. Italy Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 452. United Kingdom Brain Monitoring, by Type USD Million (2019-2024)
  • Table 453. United Kingdom Brain Monitoring, by Application USD Million (2019-2024)
  • Table 454. United Kingdom Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 455. United Kingdom Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 456. United Kingdom Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 457. Netherlands Brain Monitoring, by Type USD Million (2019-2024)
  • Table 458. Netherlands Brain Monitoring, by Application USD Million (2019-2024)
  • Table 459. Netherlands Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 460. Netherlands Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 461. Netherlands Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 462. Rest of Europe Brain Monitoring, by Type USD Million (2019-2024)
  • Table 463. Rest of Europe Brain Monitoring, by Application USD Million (2019-2024)
  • Table 464. Rest of Europe Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 465. Rest of Europe Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 466. Rest of Europe Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 467. MEA Brain Monitoring, by Country USD Million (2019-2024)
  • Table 468. MEA Brain Monitoring, by Type USD Million (2019-2024)
  • Table 469. MEA Brain Monitoring, by Application USD Million (2019-2024)
  • Table 470. MEA Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 471. MEA Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 472. MEA Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 473. Middle East Brain Monitoring, by Type USD Million (2019-2024)
  • Table 474. Middle East Brain Monitoring, by Application USD Million (2019-2024)
  • Table 475. Middle East Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 476. Middle East Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 477. Middle East Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 478. Africa Brain Monitoring, by Type USD Million (2019-2024)
  • Table 479. Africa Brain Monitoring, by Application USD Million (2019-2024)
  • Table 480. Africa Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 481. Africa Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 482. Africa Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 483. North America Brain Monitoring, by Country USD Million (2019-2024)
  • Table 484. North America Brain Monitoring, by Type USD Million (2019-2024)
  • Table 485. North America Brain Monitoring, by Application USD Million (2019-2024)
  • Table 486. North America Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 487. North America Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 488. North America Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 489. United States Brain Monitoring, by Type USD Million (2019-2024)
  • Table 490. United States Brain Monitoring, by Application USD Million (2019-2024)
  • Table 491. United States Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 492. United States Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 493. United States Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 494. Canada Brain Monitoring, by Type USD Million (2019-2024)
  • Table 495. Canada Brain Monitoring, by Application USD Million (2019-2024)
  • Table 496. Canada Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 497. Canada Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 498. Canada Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 499. Mexico Brain Monitoring, by Type USD Million (2019-2024)
  • Table 500. Mexico Brain Monitoring, by Application USD Million (2019-2024)
  • Table 501. Mexico Brain Monitoring, by Usability Type USD Million (2019-2024)
  • Table 502. Mexico Brain Monitoring, by Disease Type USD Million (2019-2024)
  • Table 503. Mexico Brain Monitoring, by Procedure Type USD Million (2019-2024)
  • Table 504. Brain Monitoring Sales: by Type(K Units)
  • Table 505. Brain Monitoring Sales Computerized Tomography (CT) Scanners , by Region K Units (2019-2024)
  • Table 506. Brain Monitoring Sales Magnetic Resonance Imaging (MRI) Scanners , by Region K Units (2019-2024)
  • Table 507. Brain Monitoring Sales Positron Emission Tomography (PET) Scanners , by Region K Units (2019-2024)
  • Table 508. Brain Monitoring Sales Electroencephalograph (EEG) Devices , by Region K Units (2019-2024)
  • Table 509. Brain Monitoring Sales Magnetoencephalography (MEG) Devices , by Region K Units (2019-2024)
  • Table 510. Brain Monitoring Sales Transcranial Doppler (TCD) Devices , by Region K Units (2019-2024)
  • Table 511. Brain Monitoring Sales Others (Sleep Monitoring Devices, Cerebral Oximeters and Others) , by Region K Units (2019-2024)
  • Table 512. Brain Monitoring Sales: by Application(K Units)
  • Table 513. Brain Monitoring Sales Hospitals , by Region K Units (2019-2024)
  • Table 514. Brain Monitoring Sales Neurology Centers , by Region K Units (2019-2024)
  • Table 515. Brain Monitoring Sales Clinics & Ambulatory Surgical Centers , by Region K Units (2019-2024)
  • Table 516. Brain Monitoring Sales Diagnostic Centers , by Region K Units (2019-2024)
  • Table 517. Brain Monitoring Sales Others (Ambulances & Others) , by Region K Units (2019-2024)
  • Table 518. Brain Monitoring Sales: by Usability Type(K Units)
  • Table 519. Brain Monitoring Sales Disposable , by Region K Units (2019-2024)
  • Table 520. Brain Monitoring Sales Reusable , by Region K Units (2019-2024)
  • Table 521. Brain Monitoring Sales: by Disease Type(K Units)
  • Table 522. Brain Monitoring Sales Dementia , by Region K Units (2019-2024)
  • Table 523. Brain Monitoring Sales Epilepsy , by Region K Units (2019-2024)
  • Table 524. Brain Monitoring Sales Huntington's Disease , by Region K Units (2019-2024)
  • Table 525. Brain Monitoring Sales Parkinson’s Disease , by Region K Units (2019-2024)
  • Table 526. Brain Monitoring Sales Traumatic Brain Injury (TBI) , by Region K Units (2019-2024)
  • Table 527. Brain Monitoring Sales Sleep Disorders , by Region K Units (2019-2024)
  • Table 528. Brain Monitoring Sales Other (Headache Disorders, Stroke and Others) , by Region K Units (2019-2024)
  • Table 529. Brain Monitoring Sales: by Procedure Type(K Units)
  • Table 530. Brain Monitoring Sales Invasive Devices , by Region K Units (2019-2024)
  • Table 531. Brain Monitoring Sales Non-invasive Devices , by Region K Units (2019-2024)
  • Table 532. South America Brain Monitoring Sales, by Country K Units (2019-2024)
  • Table 533. South America Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 534. South America Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 535. South America Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 536. South America Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 537. South America Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 538. Brazil Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 539. Brazil Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 540. Brazil Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 541. Brazil Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 542. Brazil Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 543. Argentina Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 544. Argentina Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 545. Argentina Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 546. Argentina Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 547. Argentina Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 548. Rest of South America Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 549. Rest of South America Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 550. Rest of South America Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 551. Rest of South America Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 552. Rest of South America Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 553. Asia Pacific Brain Monitoring Sales, by Country K Units (2019-2024)
  • Table 554. Asia Pacific Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 555. Asia Pacific Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 556. Asia Pacific Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 557. Asia Pacific Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 558. Asia Pacific Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 559. China Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 560. China Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 561. China Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 562. China Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 563. China Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 564. Japan Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 565. Japan Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 566. Japan Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 567. Japan Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 568. Japan Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 569. India Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 570. India Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 571. India Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 572. India Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 573. India Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 574. South Korea Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 575. South Korea Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 576. South Korea Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 577. South Korea Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 578. South Korea Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 579. Taiwan Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 580. Taiwan Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 581. Taiwan Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 582. Taiwan Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 583. Taiwan Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 584. Australia Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 585. Australia Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 586. Australia Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 587. Australia Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 588. Australia Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 589. Rest of Asia-Pacific Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 590. Rest of Asia-Pacific Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 591. Rest of Asia-Pacific Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 592. Rest of Asia-Pacific Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 593. Rest of Asia-Pacific Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 594. Europe Brain Monitoring Sales, by Country K Units (2019-2024)
  • Table 595. Europe Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 596. Europe Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 597. Europe Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 598. Europe Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 599. Europe Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 600. Germany Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 601. Germany Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 602. Germany Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 603. Germany Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 604. Germany Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 605. France Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 606. France Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 607. France Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 608. France Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 609. France Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 610. Italy Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 611. Italy Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 612. Italy Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 613. Italy Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 614. Italy Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 615. United Kingdom Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 616. United Kingdom Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 617. United Kingdom Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 618. United Kingdom Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 619. United Kingdom Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 620. Netherlands Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 621. Netherlands Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 622. Netherlands Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 623. Netherlands Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 624. Netherlands Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 625. Rest of Europe Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 626. Rest of Europe Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 627. Rest of Europe Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 628. Rest of Europe Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 629. Rest of Europe Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 630. MEA Brain Monitoring Sales, by Country K Units (2019-2024)
  • Table 631. MEA Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 632. MEA Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 633. MEA Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 634. MEA Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 635. MEA Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 636. Middle East Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 637. Middle East Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 638. Middle East Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 639. Middle East Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 640. Middle East Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 641. Africa Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 642. Africa Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 643. Africa Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 644. Africa Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 645. Africa Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 646. North America Brain Monitoring Sales, by Country K Units (2019-2024)
  • Table 647. North America Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 648. North America Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 649. North America Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 650. North America Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 651. North America Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 652. United States Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 653. United States Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 654. United States Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 655. United States Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 656. United States Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 657. Canada Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 658. Canada Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 659. Canada Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 660. Canada Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 661. Canada Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 662. Mexico Brain Monitoring Sales, by Type K Units (2019-2024)
  • Table 663. Mexico Brain Monitoring Sales, by Application K Units (2019-2024)
  • Table 664. Mexico Brain Monitoring Sales, by Usability Type K Units (2019-2024)
  • Table 665. Mexico Brain Monitoring Sales, by Disease Type K Units (2019-2024)
  • Table 666. Mexico Brain Monitoring Sales, by Procedure Type K Units (2019-2024)
  • Table 667. Brain Monitoring: by Type(USD/Units)
  • Table 668. Research Programs/Design for This Report
  • Table 669. Key Data Information from Secondary Sources
  • Table 670. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Brain Monitoring: by Type USD Million (2013-2018)
  • Figure 5. Global Brain Monitoring: by Application USD Million (2013-2018)
  • Figure 6. Global Brain Monitoring: by Usability Type USD Million (2013-2018)
  • Figure 7. Global Brain Monitoring: by Disease Type USD Million (2013-2018)
  • Figure 8. Global Brain Monitoring: by Procedure Type USD Million (2013-2018)
  • Figure 9. South America Brain Monitoring Share (%), by Country
  • Figure 10. Asia Pacific Brain Monitoring Share (%), by Country
  • Figure 11. Europe Brain Monitoring Share (%), by Country
  • Figure 12. MEA Brain Monitoring Share (%), by Country
  • Figure 13. North America Brain Monitoring Share (%), by Country
  • Figure 14. Global Brain Monitoring: by Type K Units (2013-2018)
  • Figure 15. Global Brain Monitoring: by Application K Units (2013-2018)
  • Figure 16. Global Brain Monitoring: by Usability Type K Units (2013-2018)
  • Figure 17. Global Brain Monitoring: by Disease Type K Units (2013-2018)
  • Figure 18. Global Brain Monitoring: by Procedure Type K Units (2013-2018)
  • Figure 19. South America Brain Monitoring Share (%), by Country
  • Figure 20. Asia Pacific Brain Monitoring Share (%), by Country
  • Figure 21. Europe Brain Monitoring Share (%), by Country
  • Figure 22. MEA Brain Monitoring Share (%), by Country
  • Figure 23. North America Brain Monitoring Share (%), by Country
  • Figure 24. Global Brain Monitoring: by Type USD/Units (2013-2018)
  • Figure 25. Global Brain Monitoring share by Players 2018 (%)
  • Figure 26. Global Brain Monitoring share by Players (Top 3) 2018(%)
  • Figure 27. Global Brain Monitoring share by Players (Top 5) 2018(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Advanced Brain Monitoring (United States) Revenue, Net Income and Gross profit
  • Figure 30. Advanced Brain Monitoring (United States) Revenue: by Geography 2018
  • Figure 31. Nihon Kohden Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Nihon Kohden Corporation (Japan) Revenue: by Geography 2018
  • Figure 33. Natus Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Natus Medical, Inc. (United States) Revenue: by Geography 2018
  • Figure 35. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 36. Philips Healthcare (Netherlands) Revenue: by Geography 2018
  • Figure 37. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 38. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 39. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Siemens Healthineers (Germany) Revenue: by Geography 2018
  • Figure 41. Compumedics, Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 42. Compumedics, Ltd. (Australia) Revenue: by Geography 2018
  • Figure 43. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 44. Medtronic (Ireland) Revenue: by Geography 2018
  • Figure 45. CAS Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. CAS Medical Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 47. Drägerwerk AG & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Drägerwerk AG & Co. KGaA (Germany) Revenue: by Geography 2018
  • Figure 49. Masimo Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 50. Masimo Corporation (United States) Revenue: by Geography 2018
  • Figure 51. Spiegelberg GmbH & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 52. Spiegelberg GmbH & Co. KG (Germany) Revenue: by Geography 2018
  • Figure 53. Cadwell Industries (United States) Revenue, Net Income and Gross profit
  • Figure 54. Cadwell Industries (United States) Revenue: by Geography 2018
  • Figure 55. Global Brain Monitoring: by Type USD Million (2019-2024)
  • Figure 56. Global Brain Monitoring: by Application USD Million (2019-2024)
  • Figure 57. Global Brain Monitoring: by Usability Type USD Million (2019-2024)
  • Figure 58. Global Brain Monitoring: by Disease Type USD Million (2019-2024)
  • Figure 59. Global Brain Monitoring: by Procedure Type USD Million (2019-2024)
  • Figure 60. South America Brain Monitoring Share (%), by Country
  • Figure 61. Asia Pacific Brain Monitoring Share (%), by Country
  • Figure 62. Europe Brain Monitoring Share (%), by Country
  • Figure 63. MEA Brain Monitoring Share (%), by Country
  • Figure 64. North America Brain Monitoring Share (%), by Country
  • Figure 65. Global Brain Monitoring: by Type K Units (2019-2024)
  • Figure 66. Global Brain Monitoring: by Application K Units (2019-2024)
  • Figure 67. Global Brain Monitoring: by Usability Type K Units (2019-2024)
  • Figure 68. Global Brain Monitoring: by Disease Type K Units (2019-2024)
  • Figure 69. Global Brain Monitoring: by Procedure Type K Units (2019-2024)
  • Figure 70. South America Brain Monitoring Share (%), by Country
  • Figure 71. Asia Pacific Brain Monitoring Share (%), by Country
  • Figure 72. Europe Brain Monitoring Share (%), by Country
  • Figure 73. MEA Brain Monitoring Share (%), by Country
  • Figure 74. North America Brain Monitoring Share (%), by Country
  • Figure 75. Global Brain Monitoring: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Advanced Brain Monitoring (United States)
  • Nihon Kohden Corporation (Japan)
  • Natus Medical, Inc. (United States)
  • Philips Healthcare (Netherlands)
  • GE Healthcare (United States)
  • Siemens Healthineers (Germany)
  • Compumedics, Ltd. (Australia)
  • Medtronic (Ireland)
  • CAS Medical Systems, Inc. (United States)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Masimo Corporation (United States)
  • Spiegelberg GmbH & Co. KG (Germany)
  • Cadwell Industries (United States)
Additional players considered in the study are as follows:
NeuroWave Systems, Inc. (United States) , Nonin Medical, Inc. (United States) , Integra LifeSciences Corporation (United States) , Neurosoft (Russia) , Rimed (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation